Skip to content

Clinical trials

Phase 1/2 Central Nervous System Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 1/2 Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20101
20141
20162
20172
20191
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Hoffmann-La Roche2
National Cancer Institute (NCI)2
Radiation Therapy Oncology Group2
Australian & New Zealand Children's Haematology/Oncology Group1
Blueprint Medicines Corporation1
Children's Oncology Group1
Eisai Inc.1
Helsinn Healthcare SA1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms14
Recurrence5
Brain Neoplasms3
Glioblastoma3
Glioma3
Gliosarcoma3
Neoplasms3
Thyroid Cancer, Papillary3
Breast Neoplasms2
Bronchial Neoplasms2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.